Holen Sie sich die Stockscreener-App
2.15
1.38%
-0.03
Vorhandelsmarkt:
2.05
-0.10
-4.65%
Finanzdaten der Ensysce Biosciences Inc-Aktie (ENSC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.24%
1.3198
|
1.3037 | 3.4189 | 0.1818 | 0.3057 |
Operating Expenses
|
32.64%
3.2873
|
4.8801 | 2.7741 | 2.1372 | 2.1487 |
| Benefits Costs and Expenses |
32.92%
3.2653
|
4.8681 | 2.7571 | 2.1496 | 3.4223 |
| Costs And Expenses |
32.92%
3.2653
|
4.8681 | 2.7571 | 2.1496 | 3.4223 |
| Operating Income/Loss |
44.99%
-1.9675
|
-3.5765 | 0.6447 | -1.9554 | -1.843 |
| Nonoperating Income/Loss |
82.01%
0.0219
|
0.0121 | 0.017 | -0.0124 | -1.2736 |
| Income/Loss From Continuing Operations Before Tax |
45.42%
-1.9456
|
-3.5644 | 0.6618 | -1.9678 | -3.1166 |
| Income/Loss From Continuing Operations After Tax |
45.42%
-1.9456
|
-3.5644 | 0.6618 | -1.9678 | -3.1166 |
|
Net Income/Loss
|
45.42%
-1.9456
|
-3.5644 | 0.6618 | -1.9678 | -3.1166 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
100.00%
-
|
-0.00029 | - | - | -0.000074 |
| Basic Average Shares |
119.78%
1.4011
|
-7.0849 | 9.8904 | 8.8173 | 5.6945 |
| Diluted Average Shares |
119.78%
1.4011
|
-7.0849 | 9.8904 | 8.8173 | 5.6945 |
| Basic Earnings Per Share |
87.22%
-1.39
|
-10.88 | 0.07 | -0.22 | -0.55 |
| Diluted Earnings Per Share |
87.22%
-1.39
|
-10.88 | 0.07 | -0.22 | -0.55 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):